Vera Therapeutics (VERA) Retained Earnings (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Retained Earnings came in at -$156000.0 in Q1 2026, up 99.97% YoY from -$78011.9 in Q1 2025, and down 119.85% on a QoQ basis from $786000.0 in Q4 2025.
Vera Therapeutics (VERA) Retained Earnings (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Retained Earnings data on file, last reported at -$156000.0 in Q1 2026.
- Quarterly Retained Earnings rose 99.97% year-over-year to -$156000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$156000.0 (up 99.97% YoY) and the FY2025 annual result came in at $786000.0, up 100.17% from the prior year.
- Retained Earnings retreated to -$156000.0 in Q1 2026, from $786000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $786000.0 in Q4 2025 to a low of -$669.8 million in Q3 2025.
- A 5-year average of -$154.2 million and a median of -$279000.0 in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings tumbled 557000.0% — and 2025, when it jumped 217.11%.
- Tracing VERA's Retained Earnings over 5 years: stood at -$224000.0 in 2022, then soared by 212.05% to $251000.0 in 2023, then sank by 183864.94% to -$461.2 million in 2024, then soared by 100.17% to $786000.0 in 2025, then sank by 119.85% to -$156000.0 in 2026.
- The last three Retained Earnings figures came in at -$156000.0 (Q1 2026), $786000.0 (Q4 2025), and -$669.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | -991.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -991.40 Mn |
| Mar 31, 2026 | -156,000.00 |
| Dec 31, 2025 | 786,000.00 |
| Sep 30, 2025 | -669.80 Mn |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | -512.94 Mn |
| Dec 31, 2024 | -461.25 Mn |
| Sep 30, 2024 | -417.83 Mn |
| Jun 30, 2024 | -450,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -263.30 Mn |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -224,000.00 |
| Sep 30, 2022 | -279,000.00 |
| Jun 30, 2022 | -155.99 Mn |
| Mar 31, 2022 | -141.10 Mn |
| Dec 31, 2021 | -124.06 Mn |
| Sep 30, 2021 | -107.21 Mn |